Page last updated: 2024-11-06

prednisolone and Hematologic Diseases

prednisolone has been researched along with Hematologic Diseases in 56 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research Excerpts

ExcerptRelevanceReference
"Prednimustine is an ester of chlorambucil and prednisolone."6.65A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer. ( Christiansen, IE; Dombernowsky, P; Løber, J; Mattsson, W; Mouridsen, HT; Rørth, M, 1983)
"A total of 164 patients with non-Hodgkin's lymphoma (NHL) were randomized to receive cycles of treatment every 3 weeks with either CTP, ie, cyclophosphamide (400 mg/m2/day orally X 5), teniposide (VM-26) (100 mg/m2 iv X 1), and prednisolone (60 mg/m2/day orally X 5), or COP, ie, vincristine (1."5.05Comparison of the use of teniposide and vincristine in combination chemotherapy for non-Hodgkin's lymphoma. ( , 1982)
" In our clinic, mega-dose methylprednisolone (MDMP) has been successfully used for treatment of different hematologic diseases, such as leukemias, bone marrow failure in aplastic anemia, hypoplastic anemia, myelodysplastic syndrome, neutropenia, autoimmune diseases, and in some congenital hereditary diseases."4.84Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders. ( Ozsoylu, S; Yetgin, S, 2007)
"CHOP-14 with the addition of rhG-CSF is safe and practicable in a large multicentre setting in patients aged 18-75 years."2.71Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). ( Bittner, S; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rudolph, C; Schmalenberg, H; Schmits, R; Truemper, L; Wunderlich, A, 2003)
"Prednimustine is an ester of chlorambucil and prednisolone."2.65A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer. ( Christiansen, IE; Dombernowsky, P; Løber, J; Mattsson, W; Mouridsen, HT; Rørth, M, 1983)
"Of 136 patients with solid tumors with normocalcemia, the serum parathyroid hormone-related protein concentration was slightly elevated in only 5."1.28Serum parathyroid hormone-related protein concentrations in patients with hematologic malignancies or solid tumors. ( Bando, H; Nakamura, Y; Saito, S; Shintani, Y; Yokogoshi, Y, 1992)
"Many patients with advanced Hodgkin's disease continue to need palliative therapy, but where there is no curative intent, patients and doctors may prefer oral treatment only."1.28An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNU. ( Carey, PJ; Jackson, GH; Lennard, AL; Proctor, SJ, 1990)

Research

Studies (56)

TimeframeStudies, this research(%)All Research%
pre-199035 (62.50)18.7374
1990's8 (14.29)18.2507
2000's7 (12.50)29.6817
2010's5 (8.93)24.3611
2020's1 (1.79)2.80

Authors

AuthorsStudies
Hagihara, M1
Sugi, T1
Hayashi, H1
Nakashima, S1
Ohara, S1
Imai, Y1
Nakano, H1
Uchida, T1
Inoue, M1
Mitamura, K1
Kotila, TR1
Olutogun, T1
Ipadeola, A1
Giordano, P1
Lassandro, G1
Sangerardi, M1
Faienza, MF1
Valente, F1
Martire, B1
Brannagan, TH1
Patterson, SK1
Niitsu, N1
Hayama, M1
Yoshino, T1
Nakamura, S1
Tamaru, J1
Nakamine, H1
Okamoto, M1
Dietrich, S1
Falk, CS1
Benner, A1
Karamustafa, S1
Hahn, E1
Andrulis, M1
Hegenbart, U1
Ho, AD1
Dreger, P1
Luft, T1
Wunderlich, A1
Kloess, M1
Reiser, M1
Rudolph, C1
Truemper, L1
Bittner, S1
Schmalenberg, H1
Schmits, R2
Pfreundschuh, M3
Loeffler, M3
GROSS, R2
LUDWIG, H2
DELAGE, JM1
PAWELSKI, S1
STACHER, A4
BOHNEL, J2
MARCHAL, G1
BILSKI-PASQUIER, G1
LEVY, JP1
DEBBASCH, L1
DE ANGELIS, P1
SONNINO, S1
MAZZEI, R1
van DOMMELEN, C1
FIEGEL, G1
KELLING, HW1
GERHARTZ, H1
THOMAS, K1
CUTRERA, A1
ACANFORA, D1
BOEHNEL, J2
GALLINELLI, R1
TRALDI, A1
MAGRASSI, F1
UEDA, H1
UCHIDA, Y1
KAMII, K1
KAWAI, N1
SAITO, Y1
TAGAWA, H1
MARTUCCI, E1
ZIMBALATTI, F1
NINNI, M1
BEDARIDA, G1
MONITILLO, E1
Kamen, BA1
Yetgin, S1
Ozsoylu, S1
Zwick, C2
Zeynalova, S1
Dührsen, U1
Pflüger, KH1
Vrieling, T1
Mesters, R1
Mergenthaler, HG1
Einsele, H1
Bentz, M2
Lengfelder, E1
Trümper, L2
Rübe, C1
Schmitz, N1
Ziepert, M1
Hohloch, K1
Mohren, M1
Liersch, R1
Graeven, U1
Wruck, U1
Hoffmann, M1
Metzner, B1
Hasenclever, D1
McGrath, P1
Patton, MA1
James, S1
Bogdanovich, NK1
Fleĭshman, EV1
Epifanov, NS1
Løber, J1
Mouridsen, HT1
Christiansen, IE1
Dombernowsky, P1
Mattsson, W1
Rørth, M1
Sonneveld, P1
de Ridder, M1
van der Lelie, H1
Nieuwenhuis, K1
Schouten, H1
Mulder, A1
van Reijswoud, I1
Hop, W1
Lowenberg, B1
Fridrik, MA1
Hausmaninger, H1
Linkesch, W1
Stöger, M1
Sill, H1
Neubauer, M1
Seewann, HL1
Klocker, J1
Haidinger, R1
Schiller, L1
Pont, J1
Raudaschl, G1
Falk, M1
Radaszkiewicz, T1
Welte, K1
Reiter, A1
Mempel, K1
Pfetsch, M1
Schwab, G1
Schrappe, M1
Riehm, H1
Mondal, T1
Kumar, KJ1
Chandra, J1
Simmonds, PD1
Mead, GM1
Sweetenham, JW1
O'Callaghan, A1
Smartt, P1
Kerr, J1
Hamilton, CR1
Golding, PF1
Milne, AE1
Whitehouse, JM1
Carde, P1
Cavalli, F1
Diehl, V1
Franklin, J1
Ekert, H1
Waters, KD1
Matsumoto, N1
Miwa, S1
Rowan, RM1
Nakamura, Y1
Bando, H1
Shintani, Y1
Yokogoshi, Y1
Saito, S1
Ohtsu, T1
Sai, T1
Oka, M1
Sugai, Y1
Tobinai, K1
Lennard, AL1
Carey, PJ1
Jackson, GH1
Proctor, SJ1
Meister, H1
Trux, F1
Egorova, LI1
Dacie, JV1
Mattson, K1
Golovin, GV1
Rakhimova, MZ1
Isacchi, G1
De Rossi, G1
Curró, F1
Zeĭtts, RI1
Schindler, H1
Seifert, E1
Kassirskiĭ, IA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomised Trial Comparing Chemotherapy Mit CHOEP (Cyclophosphamid, Doxorubicin, Vincristin, Etoposid Und Prednison) In 21-Day Intervals In Standard And Escalated Doses In Patients Aged 18-60 Years Of Age With Aggresive Non-Hodgkin-Lymphomas Favourable Pr[NCT00053768]Phase 3392 participants (Actual)Interventional2002-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

7 reviews available for prednisolone and Hematologic Diseases

ArticleYear
Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:4

    Topics: Apoptosis; Cell Differentiation; Female; Glucocorticoids; Hematologic Diseases; Humans; Male; Methyl

2007
Therapeutic uses of methyl prednisolone.
    Indian pediatrics, 1995, Volume: 32, Issue:7

    Topics: Asthma; Eye Diseases; Glomerulonephritis; Glucocorticoids; Hematologic Diseases; Humans; Prednisolon

1995
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
    The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials, Phase III

2000
[Steroid therapy for hematologic diseases--indications and methods of administration].
    Nihon rinsho. Japanese journal of clinical medicine, 1979, Jun-10, Volume: 37, Issue:6

    Topics: Adrenal Cortex Hormones; Agranulocytosis; Anemia, Aplastic; Anemia, Hemolytic, Autoimmune; Hematolog

1979
Riboflavin and adrenal cortex.
    Nutrition reviews, 1973, Volume: 31, Issue:3

    Topics: Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenal Glands; Adrenalectomy; Animal Nutritional P

1973
[Use of cortisol and its derivatives in clinic practice].
    Terapevticheskii arkhiv, 1967, Volume: 39, Issue:6

    Topics: Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenocorticotropic Hormone; Arthritis, Rheumatoid;

1967
[The condition of the formed elements of the blood in acute and chronic hemorrhage (a review of Soviet and foreign literature)].
    Vestnik khirurgii imeni I. I. Grekova, 1972, Volume: 108, Issue:4

    Topics: Acute Disease; Animals; Blood Cell Count; Blood Cells; Blood Platelets; Blood Sedimentation; Bone Ma

1972

Trials

12 trials available for prednisolone and Hematologic Diseases

ArticleYear
Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.
    British journal of haematology, 2011, Volume: 153, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamid

2011
Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Aged; Endothelium, Vascular; Female; Glucocorticoids; Graft vs Host Disease; Hema

2013
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha

2003
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxo

2008
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administr

2008
A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
    Cancer, 1983, Nov-01, Volume: 52, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Clinica

1983
Comparison of the use of teniposide and vincristine in combination chemotherapy for non-Hodgkin's lymphoma.
    Cancer treatment reports, 1982, Volume: 66, Issue:1

    Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hematologic Diseases; Humans; Ki

1982
Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10

    Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined

1995
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexametha

1996
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
    Blood, 1996, Apr-15, Volume: 87, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1996
PACE BOM chemotherapy: a 12-week regimen for advanced Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1997
[Double-blind study of a corticoid combination as compared with the single components in the hematologic field: preliminary data].
    La Clinica terapeutica, 1970, Sep-30, Volume: 54, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Betamethasone; Clinical Tri

1970

Other Studies

37 other studies available for prednisolone and Hematologic Diseases

ArticleYear
[Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2023, Volume: 64, Issue:2

    Topics: Anemia, Aplastic; Antibodies, Viral; COVID-19; Hematologic Diseases; Humans; Immunoglobulin G; Predn

2023
Steroid induced diabetes mellitus in patients receiving prednisolone for haematological disorders.
    African health sciences, 2013, Volume: 13, Issue:3

    Topics: Adult; Aged; Diabetes Mellitus; Drug Therapy, Combination; Female; Glucocorticoids; Hematologic Dise

2013
Autoimmune haematological disorders in two Italian children with Kabuki syndrome.
    Italian journal of pediatrics, 2014, Jan-25, Volume: 40

    Topics: Abnormalities, Multiple; Anemia, Hemolytic, Autoimmune; Biopsy, Fine-Needle; Child; Diagnosis, Diffe

2014
Alemtuzumab: the future of chronic inflammatory demyelinating polyradiculoneuropathy treatment?
    Expert review of clinical immunology, 2010, Volume: 6, Issue:3

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Female

2010
[High dosages of prednisone and prednisolone in treatment of blood diseases].
    Klinische Wochenschrift, 1956, Nov-01, Volume: 34, Issue:41-42

    Topics: Hematologic Diseases; Prednisolone; Prednisone

1956
[High dosages of prednisone and prednisolone in treatment of blood diseases].
    Klinische Wochenschrift, 1956, Nov-01, Volume: 34, Issue:41-42

    Topics: Hematologic Diseases; Prednisolone; Prednisone

1956
[High dosages of prednisone and prednisolone in treatment of blood diseases].
    Klinische Wochenschrift, 1956, Nov-01, Volume: 34, Issue:41-42

    Topics: Hematologic Diseases; Prednisolone; Prednisone

1956
[High dosages of prednisone and prednisolone in treatment of blood diseases].
    Klinische Wochenschrift, 1956, Nov-01, Volume: 34, Issue:41-42

    Topics: Hematologic Diseases; Prednisolone; Prednisone

1956
Prednisolone in hematology.
    L'union medicale du Canada, 1957, Volume: 86, Issue:4

    Topics: Hematologic Diseases; Humans; Prednisolone

1957
[Prednisone and prednisolone in the treatment of blood diseases].
    Polski tygodnik lekarski, 1957, Jul-29, Volume: 12, Issue:31

    Topics: Hematologic Diseases; Prednisolone; Prednisone

1957
[Treatment of blood diseases with prednisolone].
    Wiener medizinische Wochenschrift (1946), 1958, Jun-21, Volume: 108, Issue:25-26

    Topics: Hematologic Diseases; Humans; Prednisolone

1958
[Clinical effects of decadrols in hematology].
    Semaine medicale professionelle et medico-sociale, 1960, Dec-04, Volume: 36

    Topics: Dexamethasone; Hematologic Diseases; Hematology; Humans; Prednisolone

1960
[On the use of prednisolone in hemolytic anemia of the newborn caused by fetomaternal Rh-factor incompatibility].
    Rivista d'ostetricia e ginecologia pratica, 1960, Volume: 42

    Topics: Anemia, Hemolytic; Erythroblastosis, Fetal; Female; Fetal Therapies; Hematologic Diseases; Humans; I

1960
[Use of dexamethasone (decadron) in the internal medicine clinic].
    Nederlands tijdschrift voor geneeskunde, 1960, Mar-05, Volume: 104

    Topics: Collagen Diseases; Dexamethasone; Hematologic Diseases; Humans; Internal Medicine; Prednisolone

1960
[Effects of dexamethasone on metabolism, electrolyte balance and blood conditions].
    Munchener medizinische Wochenschrift (1950), 1959, Oct-09, Volume: 101

    Topics: Dexamethasone; Hematologic Diseases; Prednisolone; Water-Electrolyte Balance

1959
[Corticosteroid therapy of hemoblastoses].
    Arztliche Wochenschrift, 1960, Jan-01, Volume: 15

    Topics: Adrenal Cortex Hormones; Hematologic Diseases; Prednisolone

1960
[On the effect of glucocorticosteroids in hematological diseases].
    Monatsschrift fur Kinderheilkunde, 1960, Volume: 108

    Topics: Child; Hematologic Diseases; Humans; Infant; Prednisolone

1960
[The therapeutic problem of isoimmunization in its various clinical and experimental aspects].
    Rivista di ostetricia e ginecologia, 1961, Volume: 16

    Topics: Erythroblastosis, Fetal; Fetus; Hematologic Diseases; Prednisolone

1961
[Successes and hazards of highdosage cortisone (prednisolone) therapy of blood diseases].
    Die Medizinische Welt, 1962, Jun-02, Volume: 22

    Topics: Cortisone; Hematologic Diseases; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgk

1962
[BENZENE BLOOD DISEASE. 3 CASES OF CHRONIC BENZENE POISONING OF WHICH 2 WERE FATAL (ACUTE LEUKEMIA, ACUTE PANMYELOPHTHISIS)].
    La Medicina del lavoro, 1963, Volume: 54

    Topics: Adrenocorticotropic Hormone; Anemia; Anemia, Myelophthisic; Anti-Bacterial Agents; Ascorbic Acid; Be

1963
[ANTIVIRAL CHEMOTHERAPY AS A BASIS FOR CHEMOTHERAPY OF BLOOD DISEASES AND MALIGNANT NEOPLASMS].
    La Riforma medica, 1964, Feb-29, Volume: 78

    Topics: Antiviral Agents; Hematologic Diseases; Leukemia; Leukemia, Experimental; Liver; Mice; Neoplasms; On

1964
[STEROID DIABETES TERMINATING IN DEATH IN DIABETIC COMA AND THE OBSERVATION OF THE PANCREAS IN STEROID GLYCOSURIA IN HEMATOLOGIC DISEASES].
    Naika. Internal medicine, 1964, Volume: 14

    Topics: Anemia; Anemia, Aplastic; Diabetes Mellitus; Diabetic Coma; Drug Therapy; Glycosuria; Hematologic Di

1964
[EXPERIENCES WITH A PREDNISOLONE NICOTINIC ACID ESTER IN HEMATOLOGIC DISEASES].
    Therapeutische Umschau. Revue therapeutique, 1964, Volume: 21

    Topics: Drug Therapy; Hematologic Diseases; Hodgkin Disease; Leukemia; Niacin; Nicotinic Acids; Prednisolone

1964
[Contribution to the therapy of the pathological jaundice in the newborn].
    La Pediatria, 1960, Jun-15, Volume: 68

    Topics: Erythroblastosis, Fetal; Female; Fetal Therapies; Hematologic Diseases; Jaundice; Prednisolone; Preg

1960
[The therapeutic action of dexamethazone in immune blood diseases].
    Rivista di emoterapia ed immunoematologia, 1959, Volume: 6

    Topics: Hematologic Diseases; Immune System Diseases; Prednisolone

1959
Megadose methylprednisolone therapy: 2 decades of experience and empiric success in need of explanation, validation, and exploitation.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:4

    Topics: Apoptosis; Cell Differentiation; Female; Glucocorticoids; Hematologic Diseases; Humans; Male; Methyl

2007
"I was never like that": Australian findings on the psychological and psychiatric sequelae of corticosteroids in haematology treatments.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2009, Volume: 17, Issue:4

    Topics: Adult; Aged; Australia; Data Collection; Dexamethasone; Emotions; Female; Glucocorticoids; Hematolog

2009
[The hypothalamus-neurohypophysis-adrenal cortex system in prolonged corticosteroid therapy].
    Arkhiv patologii, 1966, Volume: 28, Issue:4

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adult; Collagen Diseases; Female; Hematologic Diseases; H

1966
[Splenectomy in patients with blood diseases treated by corticosteroids].
    Vestnik khirurgii imeni I. I. Grekova, 1966, Volume: 96, Issue:5

    Topics: Adrenal Insufficiency; Adrenocortical Hyperfunction; Hematologic Diseases; Humans; Prednisolone; Pre

1966
Hematologic emergencies in children.
    Paediatrician, 1978, Volume: 7, Issue:4-5

    Topics: Acute Disease; Acute Kidney Injury; Adolescent; Anemia, Aplastic; Anemia, Hemolytic, Autoimmune; Asp

1978
Myelomatosis.
    Comprehensive therapy, 1977, Volume: 3, Issue:2

    Topics: Acute Kidney Injury; Alkylating Agents; Amyloidosis; Antigens, Neoplasm; Blood Viscosity; Bone and B

1977
Serum parathyroid hormone-related protein concentrations in patients with hematologic malignancies or solid tumors.
    Acta endocrinologica, 1992, Volume: 127, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Fem

1992
Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies.
    Japanese journal of clinical oncology, 1991, Volume: 21, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Carrier State; Female; Hematologic Diseases; Hepatitis B; Humans

1991
An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNU.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambuci

1990
[Immature cell panmyelosis].
    Acta haematologica, 1973, Volume: 50, Issue:3

    Topics: Acid Phosphatase; Adult; Antibiotics, Antineoplastic; Asparaginase; Blood Transfusion; Bone Marrow E

1973
Clinical immunology and the physician. Blood.
    Proceedings of the Royal Society of Medicine, 1974, Volume: 67, Issue:6 Pt 2

    Topics: Adrenocorticotropic Hormone; Anemia, Hemolytic, Autoimmune; Anemia, Macrocytic; Blood Transfusion; C

1974
Side effects of rifampicin. A clinical study.
    Scandinavian journal of respiratory diseases. Supplementum, 1973, Volume: 82

    Topics: Acute Disease; Acute Kidney Injury; Adult; Ambulatory Care; Amylases; Chemical and Drug Induced Live

1973
[The influence of steroid hormones on the uropepsin excretion in children with diseases of the hematopoietic system].
    Pediatriia, 1966, Volume: 45, Issue:10

    Topics: Adolescent; Child; Child, Preschool; Cortisone; Endopeptidases; Hematologic Diseases; Humans; Infant

1966
[The effect of 6-alpha-fluoro-16-alpha-methyl-1-dehydro-corticosterone (fluocortolone) in internal diseases].
    Arzneimittel-Forschung, 1968, Volume: 18, Issue:3

    Topics: Acute Disease; Adrenal Insufficiency; Adult; Aged; Arthritis, Rheumatoid; Asthma; Bronchitis; Chroni

1968
[Corticosteroid therapy in diseases of the blood].
    Sovetskaia meditsina, 1966, Volume: 29, Issue:9

    Topics: Adult; Aged; Female; Hematologic Diseases; Humans; Male; Middle Aged; Prednisolone

1966